Get started
Rezolute, Inc.Rezolute, Inc.Rezolute, Inc.

Rezolute, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RZLT chart


Full chart

RZLT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪284.50 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.27 USD
Net income (FY)
‪−68.46 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪48.35 M‬
Beta (1Y)
−0.54

Employees


Employees (FY)
59
Change (1Y)
+8 +15.69%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.16 M‬ USD

About Rezolute, Inc.


Sector
Health Technology
CEO
Nevan Charles Elam
Headquarters
Redwood City
Website
rezolutebio.com
Founded
2010
FIGI
BBG001XWWHL4
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its clinical assets include Ersodetug, a potential treatment for hypoglycemia caused by multiple forms of hyperinsulinism, and RZ402, an oral plasma kallikrein inhibitor and potential therapy for the chronic treatment of diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

RZLT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RZLT is 4.91 USD — it has increased by 1.03% in the past 24 hours. Watch Rezolute, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rezolute, Inc. stocks are traded under the ticker RZLT.
RZLT stock has fallen by −12.48% compared to the previous week, the month change is a −5.58% fall, over the last year Rezolute, Inc. has showed a 513.75% increase.
We've gathered analysts' opinions on Rezolute, Inc. future price: according to them, RZLT price has a max estimate of 16.00 USD and a min estimate of 8.00 USD. Watch RZLT chart and read a more detailed Rezolute, Inc. stock forecast: see what analysts think of Rezolute, Inc. and suggest that you do with its stocks.
RZLT reached its all-time high on Jan 7, 2014 with the price of 195.00 USD, and its all-time low was 0.72 USD and was reached on Nov 30, 2023. View more price dynamics on RZLT chart.
See other stocks reaching their highest and lowest prices.
RZLT stock is 6.62% volatile and has beta coefficient of −0.54. Track Rezolute, Inc. stock price on the chart and check out the list of the most volatile stocks — is Rezolute, Inc. there?
Today Rezolute, Inc. has the market capitalization of ‪284.50 M‬, it has decreased by −8.13% over the last week.
Yes, you can track Rezolute, Inc. financials in yearly and quarterly reports right on TradingView.
Rezolute, Inc. is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
RZLT earnings for the last quarter are −0.22 USD per share, whereas the estimation was −0.33 USD resulting in a 33.91% surprise. The estimated earnings for the next quarter are −0.25 USD per share. See more details about Rezolute, Inc. earnings.
Rezolute, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
RZLT net income for the last quarter is ‪−15.38 M‬ USD, while the quarter before that showed ‪−22.98 M‬ USD of net income which accounts for 33.07% change. Track more Rezolute, Inc. financial stats to get the full picture.
No, RZLT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 59.00 employees. See our rating of the largest employees — is Rezolute, Inc. on this list?
Like other stocks, RZLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rezolute, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rezolute, Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rezolute, Inc. stock shows the neutral signal. See more of Rezolute, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.